Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
LHC165
i
Other names:
LHC165
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Novartis
Drug class:
TLR7 agonist
Related drugs:
‹
imiquimod (4)
BDC-1001 (2)
BDC-2034 (1)
AL-034 (0)
APR003 (0)
BDB018 (0)
BNT411 (0)
CV8102 (0)
EIK1001 (0)
GQ1007 (0)
MBS8 (0)
NKTR-262 (0)
RG6115 (0)
imiquimod intravesical (0)
DSP-0509 (0)
STM-416 (0)
TransCon TLR7/8 Agonist (0)
MEDI9197 (0)
imiquimod (4)
BDC-1001 (2)
BDC-2034 (1)
AL-034 (0)
APR003 (0)
BDB018 (0)
BNT411 (0)
CV8102 (0)
EIK1001 (0)
GQ1007 (0)
MBS8 (0)
NKTR-262 (0)
RG6115 (0)
imiquimod intravesical (0)
DSP-0509 (0)
STM-416 (0)
TransCon TLR7/8 Agonist (0)
MEDI9197 (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login